Position Description

GLOBAL INDUSTRY ANALYST, BIOTECHNOLOGY

#R83095
July 2021
...........................................................................................................................................................................................................................................................
THE COMPANY
Tracing our roots to 1928, Wellington Management Company, LLP is one of the world’s largest independent
investment management firms. With over US$1.3 trillion in assets under management as of 30 June 2021 we serve as
a trusted adviser to institutional clients and mutual fund sponsors in over 50 countries. Our innovative investment
solutions are built on the strength of proprietary, independent research and span nearly all segments of the global
capital markets, including equity, fixed income, multi-asset, and alternative strategies. As a private partnership whose
sole business is investment management, our long-term views and interests are aligned with those of our clients. We
are committed to attracting a talented and diverse workforce, and to fostering an open, collaborative culture of
inclusivity because we believe multiple perspectives lead to more informed investment and business decisions. As an
Equal Opportunity Employer, we welcome people with diverse life experiences, fresh ideas, and specialized subject-
matter expertise.

POSITION
We are seeking two (2) experienced equity analysts to join our Healthcare team within Global Industry Research (GIR).
Based in Boston, the Global Industry Analysts (GIAs) will be responsible for conducting research and making
recommendations on a subset of global biotech stocks respectively, as well as providing expert perspective on global
biotechnology markets/trends. The ideal candidates will conduct fundamental research that leads to differentiated
insights derived from asking innovative questions, anticipating trends, and identifying risks and potential disruptions in
a rapidly changing industry. Over time, we expect that both roles may have portfolio management responsibilities for
biotech research portfolios, and other client solutions.

ESSENTIAL SKILLS
The following essential skills are required for each role:

• Investment acumen and passion – The GIA will have a deep understanding of the biotechnology industry and
companies. The ability to identify mispricing and valuation discrepancies, make investment recommendations,
and communicate their findings to Portfolio Managers globally, who manage long-only and hedge fund
portfolios on behalf of our clients, is required. Overtime, the GIA will implement these recommendations
directly through the management of research led portfolios. The ideal candidate will be passionate about
markets with a demonstrated track record of successful stock recommendations. In addition, the GIA must
exhibit a fundamental, research oriented, bottom up approach, supported by a strong investment philosophy
and process and be able to implement ideas through an analytical framework.

• Superior collaboration and influencing skills – The successful candidate will be energized by being an
individual contributor within a highly collaborative team and embracing the benefits of overlapping lines of
company coverage and idea generation. The GIA will build strong trusting relationships internally with
colleagues and externally with company management teams. The ability to take risk and challenge investment
views is critical, as is the humility to admit mistakes and a desire to learn from others; the GIA must recognize
the benefits of diverse perspectives. The ability to communicate (both verbally and in writing) action-oriented
opinions clearly and with conviction, and contribute to an open investment dialogue, is important.

1
Position Description
Global Industry Analyst – Biotechnology
...........................................................................................................................................................................................................................................................

• Growth mindset – The flexibility and openness to continue learning, evolving and growing as an investor is
required. The GIA will have a global perspective and creative approach for thinking about innovation and the
next generation of the investment industry and evolution of the biotechnology sector within it.

OTHER QUALIFICATIONS
Additional qualifications and characteristics include:
• A minimum of 7 years of relevant experience analyzing stocks, preferably on the buy- or sell-side. Experience
shorting equities is desired;
• Technical and scientific expertise in analyzing biotechnology companies;
• Service orientation with a fiduciary and client-centric mindset;
• Ability to remain focused and appropriately allocate time to “what matters;”
• History of professional achievement;
• Highest personal and professional integrity and ethics; and
• Superior academic credentials and track record: an undergraduate degree; a MD or PhD in a biomedical
discipline is strongly preferred; and an MBA/CFA is desirable.